Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.
about
Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?Investigations of botanicals on food intake, satiety, weight loss and oxidative stress: study protocol of a double-blind, placebo-controlled, crossover studyNeuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.Use of cereal fiber to facilitate adherence to a human caloric restriction programEffect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesityThe effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial.Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite and gut hormones in overweight women.Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans.Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weightGlucagon-like peptide-1 regulation of carbohydrate intake is differentially affected by obesogenic diets.Effect of calorie restriction on subjective ratings of appetiteEffect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.The effect of fiber on satiety and food intake: a systematic review.Intestinal GLP-1 and satiation: from man to rodents and back.Is there any interplay between incretins and bile acids? What is the role of bariatric surgery?Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Distinct breakfast patterns on satiety perception in individuals with weight excess.Effects of sleep fragmentation on appetite and related hormone concentrations over 24 h in healthy men.GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption.Scientific Opinion on the substantiation of health claims related to guar gum and maintenance of normal blood glucose concentrations (ID 794), increase in satiety (ID 795) and maintenance of normal blood cholesterol concentrations (ID 808) pursuan...Scientific Opinion on the substantiation of health claims related to partially hydrolysed guar gum and increase in satiety (ID 790), maintenance or achievement of a normal body weight (ID 790), maintenance of normal blood concentrations of triglyc...Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.Cerebrospinal fluid xenin levels during body mass reduction: no evidence for obesity-associated defective transport across the blood-brain barrier.Effects of a 3-month supplementation with a novel soluble highly viscous polysaccharide on anthropometry and blood lipids in nondieting overweight or obese adults.Cardiovascular responses to sugary drinks in humans: galactose presents milder cardiac effects than glucose or fructose.
P2860
Q26779389-8016F642-1190-4777-A2B7-996FD59DAD68Q28468694-568983F2-6067-452B-A220-BDCBE6FF1AF5Q33606106-2786A944-9E43-4F03-A2BE-77F99ABD6754Q33848108-D03AC1B2-BB36-400B-B629-AD080FB9B7F0Q34025992-EB57B723-E42F-4CDB-B0FB-93D7E2A32ED2Q35042329-99B46D31-624F-47DB-8EE5-9CDC389927D6Q35131405-D1B457BF-3F78-4E80-8A73-C694F1BBD958Q36010043-9CD1E8D2-3F81-444B-8A94-90252AD836A6Q36297735-EBB9C291-FA4C-4D45-80C4-1F25518F3252Q36701866-C26E484F-FC39-4ABB-8CF4-21E28542DE29Q37267210-FC2BB8B4-0308-4360-BB29-1E4B296EC105Q37366007-A902947F-524D-4014-B4C9-6B8EF1D14A35Q37501257-75725551-119D-4102-A683-5523B5BB7771Q38101677-94A9C552-5D33-4512-AD56-1599802714ECQ38124088-E812A3A2-76AA-4BA7-936E-6B4EE75CA3BEQ38575560-88661F75-3E4C-4928-96A7-F18275452508Q38623207-D90E702C-65D7-4EBE-B5EA-57E30CFBB8D3Q39047697-F7454B7A-FF3D-48D9-B686-2DA7C1C83D76Q39972383-99C06B78-EF0D-4152-B9E1-564BEC461DB7Q44125696-24778ABA-F5F1-437F-96A2-E5BB81981E3BQ45066824-27E6DE3B-A0AE-4220-91D5-31F63C3FA31AQ45356659-30D2B6C1-4550-4AF6-A194-DBA47274C77BQ47147885-B204944C-0703-40EE-9A35-4B7D62677CE9Q47147888-BE697559-A1F9-419A-B0BE-D1A19C8E4537Q47864434-AB784C96-D5CA-45F4-B19F-B440DD8B762EQ48208276-458AA7A7-88D8-452A-95F7-B1166392FEA3Q48539412-1145CAB2-5548-402C-B924-EB17ABD1A657Q51491155-5F18CBE5-73CB-4C25-AAC6-1790F665A979Q53780451-530F4A13-A657-4598-BD5C-CC4B04CD9434
P2860
Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@en
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@nl
type
label
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@en
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@nl
prefLabel
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@en
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@nl
P2860
P356
P1476
Glucagon-like peptide-1 releas ...... mal-weight and obese subjects.
@en
P2093
Margriet S Westerterp-Plantenga
Tanja C M Adam
P2860
P304
P356
10.1079/BJN20041335
P577
2005-06-01T00:00:00Z